MYDRIAFAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mydriafair, and when can generic versions of Mydriafair launch?
Mydriafair is a drug marketed by Pharmafair and is included in two NDAs.
The generic ingredient in MYDRIAFAIR is tropicamide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tropicamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mydriafair
A generic version of MYDRIAFAIR was approved as tropicamide by BAUSCH AND LOMB on July 27th, 1994.
Summary for MYDRIAFAIR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Patent Applications: | 4,112 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYDRIAFAIR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYDRIAFAIR
US Patents and Regulatory Information for MYDRIAFAIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmafair | MYDRIAFAIR | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 088274-001 | Sep 16, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmafair | MYDRIAFAIR | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 088230-001 | Sep 16, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |